Efficacy and safety of influenza vaccination during chemotherapy treatment

Journal of Supportive Oncology

Volumn 8, Issue 6, 2010, Pages 271-272

  Tiseo, M ^a   Calatafimi, B ^a   Ferri, L ^a   Menardi, A ^a   Ardizzoni, A ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTHRALGIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA; INFLUENZA VACCINATION; MUSCLE DISEASE; NEOPLASM; PATIENT COMPLIANCE; PATIENT SAFETY; TRANSIENT MUSCLE SORENESS; VACCINATION REACTION;

AGED; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; NEOPLASMS; VACCINATION;

EID: 78751472268     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suponc.2010.10.004     Document Type: Article

References (6)

1. Yee SS, Dutta PR, Solin LJ, Vapiwala N, Kao GD. Lack of compliance with national vaccination guidelines in oncology patients receiving radiation therapy. J Support Oncol 2010;8:28-34.
2. Pollyea DA, Brown JMY, Horning SJ. Utility of influenza vaccination for oncology patients. J Clin Oncol 2010;28:2481-2490.
3. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med 1982;142:85-89.
4. National Patient Safety Goals. 2010. The Joint Commission. www. jointcommission.org/PatientSafety/NationalPatientSafetyGoals/. Accessed July 8, 2010.
5. Vaccine-Preventable Adult Diseases. Influenza (flu). Centers for Disease Control and Prevention. www.cdc.gov/vaccines/vpd-vac/adultvpd.htm#flu. Accessed July 8, 2010.
6. Loulergue P, Mir O, Alexandre J, Ropert S, Goldwasser F, Launay O. Low influenza vaccination rate among patients receiving chemotherapy for cancer. Ann Oncol 2008;19:1658